Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Sadif Analytics Prime
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ellex Medical Lasers Ltd announces further positive data for 2RT treatment of early AMD

Wednesday, 21 May 2014 09:00am EDT 

Ellex Medical Lasers Ltd:Announces data from a 24-month follow up of the pilot study investigating the efficacy of the company's Retinal Rejuvenation Therapy (2RT) in the treatment of early AMD.The data was presented in summary form by Dr. Erica L. Fletcher of the University of Melbourne, at the Association for Research in Vision and Ophthalmology (ARVO) 2014 Annual Meeting in Orlando, FL and is currently being considered for publication in a peer-reviewed journal.The study showed that nanosecond laser treatment reduced drusen area in 35-40 pct of treated eyes after 12 and 24 months, compared with reduced drusen area in 5-11 pct of eyes in the natural history cohort. 

Company Quote

23 Jan 2015